SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Alcohol-Related Disorders D019973 3 associated lipids
Urinary Incontinence D014549 4 associated lipids
Lead Poisoning D007855 4 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Dyspepsia D004415 5 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Amnesia D000647 12 associated lipids
Glucose Intolerance D018149 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Brain Infarction D020520 17 associated lipids
Angina Pectoris D000787 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometriosis D004715 29 associated lipids
Stroke D020521 32 associated lipids
Memory Disorders D008569 33 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Cataract D002386 34 associated lipids
Burns D002056 34 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Fever D005334 35 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Zhu G et al. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice. 2014 Phytother Res pmid:23512787
Bai S et al. Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat. 2013 Regul. Pept. pmid:23523569
Tian F et al. The neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats. 2013 Neurosci. Lett. pmid:23570727
Zhang E et al. [Formulation optimization and drug release in vitro of membrane controlled tablets of puerarin inclusion compound]. 2013 Zhongguo Zhong Yao Za Zhi pmid:23596875
Li N et al. Determination of glibenclamide and puerarin in rat plasma by UPLC-MS/MS: application to their pharmacokinetic interaction study. 2013 Talanta pmid:23597896
Li R et al. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. 2013 Brain Res. pmid:23603411
Wang Y et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. 2013 Phytomedicine pmid:23639192
Chen F et al. Puerarin-induced immune hemolytic anemia. 2013 Int. J. Hematol. pmid:23661032
Cao WL et al. [Effect of puerarin on hemorheology and pulmonary pressure in rat pneumo-cardiac disease]. 2013 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:23662397
Huang ZG et al. [Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]. 2013 Zhongguo Zhong Yao Za Zhi pmid:23668014
Zhang Y et al. Effects of puerarin on cholinergic enzymes in the brain of ovariectomized guinea pigs. 2013 Int. J. Neurosci. pmid:23668913
Chen X et al. Puerarin improves metabolic function leading to hepatoprotective effects in chronic alcohol-induced liver injury in rats. 2013 Phytomedicine pmid:23669266
Ji O et al. [Effect of flavonoids of puerarin on the proliferation and apoptosis of retinoic acid resistant acute promyelocytic leukemia cell line NB4-R1 cells]. 2013 Zhonghua Xue Ye Xue Za Zhi pmid:23688762
Chen YG et al. Metabolic differentiations of Pueraria lobata and Pueraria thomsonii using ¹H NMR spectroscopy and multivariate statistical analysis. 2014 J Pharm Biomed Anal pmid:23746990
Li R et al. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway. 2013 Brain Res. pmid:23747813
Li R et al. Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats. 2013 Int. Immunopharmacol. pmid:23751897
Xia DZ et al. Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: a randomized controlled trial. 2013 Food Chem. Toxicol. pmid:23764356
Liu X et al. Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiological states. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23774247
Wong KH et al. Differentiation of Pueraria lobata and Pueraria thomsonii using partial least square discriminant analysis (PLS-DA). 2013 J Pharm Biomed Anal pmid:23777642
Cheng M et al. Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions. 2013 J. Cardiovasc. Pharmacol. pmid:23792702
Xu L et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. 2013 Phytomedicine pmid:23856441
Zhao LX et al. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. 2013 Biol. Pharm. Bull. pmid:23902970
Yuan Y et al. Puerarin attenuates pressure overload-induced cardiac hypertrophy. 2014 J Cardiol pmid:23906530
Ji M et al. Puerarin suppresses proliferation of endometriotic stromal cells in part via differential recruitment of nuclear receptor coregulators to estrogen receptor-α. 2013 J. Steroid Biochem. Mol. Biol. pmid:23907019
Wu K et al. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. 2013 Food Chem. Toxicol. pmid:23927877
Wu X et al. Isolation, identification and pharmacokinetic analysis of fructosyl puerarins from enzymatic glycosylation. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23948238
Zhou A et al. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. 2014 Pharm Dev Technol pmid:23978005
Wang JW et al. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. 2014 J. Surg. Res. pmid:24079811
Cheng Y et al. Effects of puerarin on cardiac differentiation and ventricular specialization of murine embryonic stem cells. 2013 Cell. Physiol. Biochem. pmid:24080853
Tu L et al. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. 2013 Int J Pharm pmid:24120729
Liu Y et al. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways. 2014 Chin J Integr Med pmid:24122632
Wang Y et al. Simultaneous determination of four components in Baige capsule by HPLC: application to pharmacokinetics and tissue distribution of normal and middle cerebral artery occlusion rats. 2014 Biomed. Chromatogr. pmid:24122939
Cui YH et al. [Adsorption and isolation of macroporous resin for three isoflavonoids from puerariae lobatae radix]. 2013 Zhong Yao Cai pmid:24134015
Singh AK et al. Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. 2013 J Med Food pmid:24138167
Liu Q et al. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate. 2014 Pharm. Res. pmid:24242937
Tang TT et al. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. 2013 Int J Nanomedicine pmid:24277986
Wang N et al. Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. 2014 Neuropharmacology pmid:24333675
Zhou YX et al. Puerarin: a review of pharmacological effects. 2014 Phytother Res pmid:24339367
Zhou Y et al. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. 2014 Int. J. Neuropsychopharmacol. pmid:24345484
Mahdy HM et al. Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: possible neuromodulation and antioxidant mechanisms. 2014 Neurochem. Res. pmid:24346712
Liu AC et al. LC-MS/MS method for the determination of a new puerarin derivative and its application in pharmacokinetic studies in rats. 2013 Chin J Nat Med pmid:24359785
Tang F et al. Puerarin protects against Staphylococcus aureus-induced injury of human alveolar epithelial A549 cells via downregulating alpha-hemolysin secretion. 2014 Microb. Drug Resist. pmid:24372183
Liu S et al. Puerarin blocks the signaling transmission mediated by P2X3 in SG and DRG to relieve myocardial ischemic damage. 2014 Brain Res. Bull. pmid:24447636
Zhong Y et al. Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. 2014 PLoS ONE pmid:24454919
Liao D et al. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation. 2015 Drug Deliv pmid:24467620
Xu J et al. A new flavonoid glycoside from the rhizomes and roots of Smilax scobinicaulis. 2014 Nat. Prod. Res. pmid:24483603
Tang L et al. The protective effects of puerarin in cardiomyocytes from anoxia/reoxygenation injury are mediated by PKCε. 2014 Cell Biochem. Funct. pmid:24496955
Liu G et al. Puerarin protects against lead-induced cytotoxicity in cultured primary rat proximal tubular cells. 2014 Hum Exp Toxicol pmid:24505050
Bao L et al. The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits. 2015 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:24510110
Qu H et al. Development of an enzyme-linked immunosorbent assay based on anti-puerarin monoclonal antibody and its applications. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:24583873